Roeder RG (September 1996). "The role of general initiation factors in transcription by RNA polymerase II". Trends in Biochemical Sciences. 21 (9): 327–35. doi:10.1016/S0968-0004(96)10050-5. PMID8870495.
Thomas MC, Chiang CM (2006). "The general transcription machinery and general cofactors". Critical Reviews in Biochemistry and Molecular Biology. 41 (3): 105–78. doi:10.1080/10409230600648736. PMID16858867. S2CID13073440.
Pawson T (1993). "Signal transduction--a conserved pathway from the membrane to the nucleus". Developmental Genetics. 14 (5): 333–8. doi:10.1002/dvg.1020140502. PMID8293575.
Wheaton K, Atadja P, Riabowol K (1996). "Regulation of transcription factor activity during cellular aging". Biochemistry and Cell Biology. 74 (4): 523–34. doi:10.1139/o96-056. PMID8960358.
Meyyappan M, Atadja PW, Riabowol KT (1996). "Regulation of gene expression and transcription factor binding activity during cellular aging". Biological Signals. 5 (3): 130–8. doi:10.1159/000109183. PMID8864058.
Evan G, Harrington E, Fanidi A, Land H, Amati B, Bennett M (August 1994). "Integrated control of cell proliferation and cell death by the c-myc oncogene". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 345 (1313): 269–75. Bibcode:1994RSPTB.345..269E. doi:10.1098/rstb.1994.0105. PMID7846125.
Amoutzias GD, Robertson DL, Van de Peer Y, Oliver SG (May 2008). "Choose your partners: dimerization in eukaryotic transcription factors". Trends in Biochemical Sciences. 33 (5): 220–9. doi:10.1016/j.tibs.2008.02.002. PMID18406148.
Copland JA, Sheffield-Moore M, Koldzic-Zivanovic N, Gentry S, Lamprou G, Tzortzatou-Stathopoulou F, et al. (June 2009). "Sex steroid receptors in skeletal differentiation and epithelial neoplasia: is tissue-specific intervention possible?". BioEssays. 31 (6): 629–41. doi:10.1002/bies.200800138. PMID19382224. S2CID205469320.
Weber M, Hellmann I, Stadler MB, Ramos L, Pääbo S, Rebhan M, et al. (April 2007). "Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome". Nat. Genet. 39 (4): 457–66. doi:10.1038/ng1990. PMID17334365. S2CID22446734.
Wintjens R, Rooman M (September 1996). "Structural classification of HTH DNA-binding domains and protein-DNA interaction modes". Journal of Molecular Biology. 262 (2): 294–313. doi:10.1006/jmbi.1996.0514. PMID8831795.
Laity JH, Lee BM, Wright PE (February 2001). "Zinc finger proteins: new insights into structural and functional diversity". Current Opinion in Structural Biology. 11 (1): 39–46. doi:10.1016/S0959-440X(00)00167-6. PMID11179890.
Wolfe SA, Nekludova L, Pabo CO (2000). "DNA recognition by Cys2His2 zinc finger proteins". Annual Review of Biophysics and Biomolecular Structure. 29: 183–212. doi:10.1146/annurev.biophys.29.1.183. PMID10940247.
Libermann TA, Zerbini LF (February 2006). "Targeting transcription factors for cancer gene therapy". Current Gene Therapy. 6 (1): 17–33. doi:10.2174/156652306775515501. PMID16475943.
Moretti P, Zoghbi HY (June 2006). "MeCP2 dysfunction in Rett syndrome and related disorders". Current Opinion in Genetics & Development. 16 (3): 276–81. doi:10.1016/j.gde.2006.04.009. PMID16647848.
Lennon PA, Cooper ML, Peiffer DA, Gunderson KL, Patel A, Peters S, et al. (April 2007). "Deletion of 7q31.1 supports involvement of FOXP2 in language impairment: clinical report and review". American Journal of Medical Genetics. Part A. 143A (8): 791–8. doi:10.1002/ajmg.a.31632. PMID17330859. S2CID22021740.
Overington JP, Al-Lazikani B, Hopkins AL (December 2006). "How many drug targets are there?". Nature Reviews. Drug Discovery. 5 (12): 993–6. doi:10.1038/nrd2199. PMID17139284. S2CID11979420.
Gronemeyer H, Gustafsson JA, Laudet V (November 2004). "Principles for modulation of the nuclear receptor superfamily". Nature Reviews. Drug Discovery. 3 (11): 950–64. doi:10.1038/nrd1551. PMID15520817. S2CID205475111.
Papavassiliou AG (August 1998). "Transcription-factor-modulating agents: precision and selectivity in drug design". Molecular Medicine Today. 4 (8): 358–66. doi:10.1016/S1357-4310(98)01303-3. PMID9755455.
Ghosh D, Papavassiliou AG (2005). "Transcription factor therapeutics: long-shot or lodestone". Current Medicinal Chemistry. 12 (6): 691–701. doi:10.2174/0929867053202197. PMID15790306.
Evan G, Harrington E, Fanidi A, Land H, Amati B, Bennett M (August 1994). "Integrated control of cell proliferation and cell death by the c-myc oncogene". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 345 (1313): 269–75. Bibcode:1994RSPTB.345..269E. doi:10.1098/rstb.1994.0105. PMID7846125.
Roeder RG (September 1996). "The role of general initiation factors in transcription by RNA polymerase II". Trends in Biochemical Sciences. 21 (9): 327–35. doi:10.1016/S0968-0004(96)10050-5. PMID8870495.
Thomas MC, Chiang CM (2006). "The general transcription machinery and general cofactors". Critical Reviews in Biochemistry and Molecular Biology. 41 (3): 105–78. doi:10.1080/10409230600648736. PMID16858867. S2CID13073440.
Pawson T (1993). "Signal transduction--a conserved pathway from the membrane to the nucleus". Developmental Genetics. 14 (5): 333–8. doi:10.1002/dvg.1020140502. PMID8293575.
Osborne CK, Schiff R, Fuqua SA, Shou J (December 2001). "Estrogen receptor: current understanding of its activation and modulation". Clinical Cancer Research. 7 (12 Suppl): 4338s –4342s, discussion 4411s–4412s. PMID11916222.
Wheaton K, Atadja P, Riabowol K (1996). "Regulation of transcription factor activity during cellular aging". Biochemistry and Cell Biology. 74 (4): 523–34. doi:10.1139/o96-056. PMID8960358.
Meyyappan M, Atadja PW, Riabowol KT (1996). "Regulation of gene expression and transcription factor binding activity during cellular aging". Biological Signals. 5 (3): 130–8. doi:10.1159/000109183. PMID8864058.
Evan G, Harrington E, Fanidi A, Land H, Amati B, Bennett M (August 1994). "Integrated control of cell proliferation and cell death by the c-myc oncogene". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 345 (1313): 269–75. Bibcode:1994RSPTB.345..269E. doi:10.1098/rstb.1994.0105. PMID7846125.
Whiteside ST, Goodbourn S (April 1993). "Signal transduction and nuclear targeting: regulation of transcription factor activity by subcellular localisation". Journal of Cell Science. 104 (4): 949–55. doi:10.1242/jcs.104.4.949. PMID8314906.
Bohmann D (November 1990). "Transcription factor phosphorylation: a link between signal transduction and the regulation of gene expression". Cancer Cells. 2 (11): 337–44. PMID2149275.
Amoutzias GD, Robertson DL, Van de Peer Y, Oliver SG (May 2008). "Choose your partners: dimerization in eukaryotic transcription factors". Trends in Biochemical Sciences. 33 (5): 220–9. doi:10.1016/j.tibs.2008.02.002. PMID18406148.
Copland JA, Sheffield-Moore M, Koldzic-Zivanovic N, Gentry S, Lamprou G, Tzortzatou-Stathopoulou F, et al. (June 2009). "Sex steroid receptors in skeletal differentiation and epithelial neoplasia: is tissue-specific intervention possible?". BioEssays. 31 (6): 629–41. doi:10.1002/bies.200800138. PMID19382224. S2CID205469320.
Weber M, Hellmann I, Stadler MB, Ramos L, Pääbo S, Rebhan M, et al. (April 2007). "Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome". Nat. Genet. 39 (4): 457–66. doi:10.1038/ng1990. PMID17334365. S2CID22446734.
Wintjens R, Rooman M (September 1996). "Structural classification of HTH DNA-binding domains and protein-DNA interaction modes". Journal of Molecular Biology. 262 (2): 294–313. doi:10.1006/jmbi.1996.0514. PMID8831795.
Laity JH, Lee BM, Wright PE (February 2001). "Zinc finger proteins: new insights into structural and functional diversity". Current Opinion in Structural Biology. 11 (1): 39–46. doi:10.1016/S0959-440X(00)00167-6. PMID11179890.
Wolfe SA, Nekludova L, Pabo CO (2000). "DNA recognition by Cys2His2 zinc finger proteins". Annual Review of Biophysics and Biomolecular Structure. 29: 183–212. doi:10.1146/annurev.biophys.29.1.183. PMID10940247.
Libermann TA, Zerbini LF (February 2006). "Targeting transcription factors for cancer gene therapy". Current Gene Therapy. 6 (1): 17–33. doi:10.2174/156652306775515501. PMID16475943.
Moretti P, Zoghbi HY (June 2006). "MeCP2 dysfunction in Rett syndrome and related disorders". Current Opinion in Genetics & Development. 16 (3): 276–81. doi:10.1016/j.gde.2006.04.009. PMID16647848.
Lennon PA, Cooper ML, Peiffer DA, Gunderson KL, Patel A, Peters S, et al. (April 2007). "Deletion of 7q31.1 supports involvement of FOXP2 in language impairment: clinical report and review". American Journal of Medical Genetics. Part A. 143A (8): 791–8. doi:10.1002/ajmg.a.31632. PMID17330859. S2CID22021740.
Overington JP, Al-Lazikani B, Hopkins AL (December 2006). "How many drug targets are there?". Nature Reviews. Drug Discovery. 5 (12): 993–6. doi:10.1038/nrd2199. PMID17139284. S2CID11979420.
Gronemeyer H, Gustafsson JA, Laudet V (November 2004). "Principles for modulation of the nuclear receptor superfamily". Nature Reviews. Drug Discovery. 3 (11): 950–64. doi:10.1038/nrd1551. PMID15520817. S2CID205475111.
Bustin SA, McKay IA (June 1994). "Transcription factors: targets for new designer drugs". British Journal of Biomedical Science. 51 (2): 147–57. PMID8049612.
Papavassiliou AG (August 1998). "Transcription-factor-modulating agents: precision and selectivity in drug design". Molecular Medicine Today. 4 (8): 358–66. doi:10.1016/S1357-4310(98)01303-3. PMID9755455.
Ghosh D, Papavassiliou AG (2005). "Transcription factor therapeutics: long-shot or lodestone". Current Medicinal Chemistry. 12 (6): 691–701. doi:10.2174/0929867053202197. PMID15790306.
Thomas MC, Chiang CM (2006). "The general transcription machinery and general cofactors". Critical Reviews in Biochemistry and Molecular Biology. 41 (3): 105–78. doi:10.1080/10409230600648736. PMID16858867. S2CID13073440.
Copland JA, Sheffield-Moore M, Koldzic-Zivanovic N, Gentry S, Lamprou G, Tzortzatou-Stathopoulou F, et al. (June 2009). "Sex steroid receptors in skeletal differentiation and epithelial neoplasia: is tissue-specific intervention possible?". BioEssays. 31 (6): 629–41. doi:10.1002/bies.200800138. PMID19382224. S2CID205469320.
Weber M, Hellmann I, Stadler MB, Ramos L, Pääbo S, Rebhan M, et al. (April 2007). "Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome". Nat. Genet. 39 (4): 457–66. doi:10.1038/ng1990. PMID17334365. S2CID22446734.
Lennon PA, Cooper ML, Peiffer DA, Gunderson KL, Patel A, Peters S, et al. (April 2007). "Deletion of 7q31.1 supports involvement of FOXP2 in language impairment: clinical report and review". American Journal of Medical Genetics. Part A. 143A (8): 791–8. doi:10.1002/ajmg.a.31632. PMID17330859. S2CID22021740.
Overington JP, Al-Lazikani B, Hopkins AL (December 2006). "How many drug targets are there?". Nature Reviews. Drug Discovery. 5 (12): 993–6. doi:10.1038/nrd2199. PMID17139284. S2CID11979420.
Gronemeyer H, Gustafsson JA, Laudet V (November 2004). "Principles for modulation of the nuclear receptor superfamily". Nature Reviews. Drug Discovery. 3 (11): 950–64. doi:10.1038/nrd1551. PMID15520817. S2CID205475111.